Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria

Fig. 2

Cut-off point of U-FABP4 level to predict MCNS in patients with nephrotic-range proteinuria. Receiver operating characteristic curve analysis to determine the cut-off points of urinary fatty acid-binding protein 4 (U-FABP4) level for prediction of minimal change nephrotic syndrome (MCNS) in patients who had nephrotic-range proteinuria (≥ 3.5 g/gCr, n = 25)

Back to article page